You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 25 No. 6, December 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (60)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Myoclonic Epilepsy With Lafora Bodies

Some Ultrastructural, Histochemical, and Biochemical Aspects

Pierluigi Gambetti, MD; Salvatore Di Mauro, MD; Lieselotte Hirt; Robert P. Blume, MD

Arch Neurol. 1971;25(6):483-493.


Abstract

The ultrastructural cytochemical study of a brain biopsy and the biochemical study of a muscle biopsy from a 20-year-old girl with typical familial progressive myoclonic epilepsy of Lafora body type yielded the following findings: No evidence of acid phosphatase activity was observed in the great majority of the Lafora bodies, indicating that they do not undergo a hydrolytic degradative process. Both filamentous and amorphous components of Lafora bodies were stained with silver proteinate, a method to detect polysaccharides, and both were digested after incubation with {gamma}-amylase, suggesting that both components of Lafora bodies are polyglucosans, probably in a different state of aggregation. The biochemical study of the muscle revealed twice the normal concentration of glycogen but no defect was found in the activities of the main enzymes of the glycogenosynthetic and glycogenolytic pathways.



Author Affiliations

Philadelphia; Pittsburgh

From the Division of Neuropathology, Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia (Drs. Gambetti and Di Mauro, and Miss Hirt), and the Department of Neurology, Mercy Hospital, Pittsburgh (Dr. Blume). Dr. Di Mauro is a fellow of the Muscular Dystrophy Association of America.


Footnotes

Accepted for publication May 22, 1971.

Reprint requests to University of Pennsylvania School of Medicine, 447 Johnson Pavilion, Philadelphia 19104 (Dr. Gambetti).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Deletions and missense mutations of EPM2A exacerbate unfolded protein response and apoptosis of neuronal cells induced by endoplasm reticulum stress
Liu et al.
Hum Mol Genet 2009;18:2622-2631.
ABSTRACT | FULL TEXT  

Dimerization of Laforin Is Required for Its Optimal Phosphatase Activity, Regulation of GSK3beta Phosphorylation, and Wnt Signaling
Liu et al.
J. Biol. Chem. 2006;281:34768-34774.
ABSTRACT | FULL TEXT  

Laforin, a Dual Specificity Phosphatase That Dephosphorylates Complex Carbohydrates
Worby et al.
J. Biol. Chem. 2006;281:30412-30418.
ABSTRACT | FULL TEXT  

Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy
Chan et al.
Hum Mol Genet 2004;13:1117-1129.
ABSTRACT | FULL TEXT  

Diagnosis of Rare Dementia Syndromes: An Algorithmic Approach
Reichman and Cummings
J Geriatr Psychiatry Neurol 1990;3:73-84.
ABSTRACT  

Muscle in Lafora Disease
Coleman et al.
Arch Neurol 1974;31:396-406.
ABSTRACT  

Studies in Myoclonus Epilepsy (Lafora Body Form) IV. Skeletal Muscle Abnormalities
Neville et al.
Arch Neurol 1974;30:466-474.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.